ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "sGC Activator Avenciguat for CKD"
Episode Synopsis
Dr. Hiddo J.L. Heerspink discusses the findings from his study, "Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials" with JASN Editor-in-Chief Rajnish Mehrotra.
More episodes of the podcast Journal of the American Society of Nephrology (JASN)
ASN Kidney Translation Series: ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives
18/09/2025
RNA Sequencing of IgA Nephropathy Kidneys
10/09/2025
The PEER-HD Randomized Controlled Trial
10/07/2025
Disaster Management in Kidney Care
25/06/2025
Drug Screening in Drosophila Nephrocytes
14/05/2025
In God we trust